HHLR Advisors, Ltd.

Institutional investor · Portfolio as of Q2 2026

Q2 2026 biggest moves

Reported value$1.7B → $832M

  • PDDPDD

    PDD Holdings

    Cut 88%

    now 4.6% of portfolio

  • ONCONC

    BeOne Medicines

    Sold out

    was 18% of portfolio

  • BABABABA

    Alibaba

    Cut 93%

    now 2.1% of portfolio

  • VIPSVIPS

    Vipshop

    28× the shares

    now 5.5% of portfolio

28 changes in all

Top Holdings35 positions

Checking export access…
Activity:
LEGN
LEGN
ADR

Legend Biotech Corporation

6M$172.8M20.8%$51.94-44.40%
25 qtrssince 2020-Q2
Unchanged
0
FUTU
FUTU
ADR

Futu Holdings Limited

1.8M$165.8M19.9%$93.53+0.22%
9 qtrssince 2024-Q2
Increased
73
AVBP

ArriVent BioPharma, Inc.

3.9M$136.5M16.4%$17.95+93.59%
10 qtrssince 2024-Q1
Unchanged
0
MRVL

Marvell Technology, Inc.

162,933$48.5M5.8%$98.95+200.90%
2 qtrssince 2026-Q1
Decreased
0
VIPS
VIPS
ADR

Vipshop Holdings Limited

3.5M$46M5.5%$13.33-0.49%
2 qtrssince 2026-Q1
Increased
93
PDD
PDD
ADR

PDD Holdings Inc.

500,000$38.1M4.6%$113.43-32.75%
17 qtrssince 2022-Q2
Decreased
0
BEKE
BEKE
ADR

KE Holdings Inc

2.2M$32.2M3.9%$20.87-30.37%
24 qtrssince 2020-Q3
Decreased
0
CTKB

Cytek Biosciences, Inc.

6.7M$29.5M3.5%$21.41-79.31%
20 qtrssince 2021-Q3
Unchanged
0
ALMR

Alamar Biosciences, Inc.

956,462$25.9M3.1%$27.090.00%
1 qtr
New
80
BABA
BABA
ADR

Alibaba Group Holding Limited

183,934$17.7M2.1%$144.74-33.69%
17 qtrssince 2022-Q2
Decreased
0
ODTX

Odyssey Therapeutics, Inc.

831,656$15.6M1.9%$18.710.00%
1 qtr
New
65
YS
YSG
ADR

Yatsen Holding Limited

4.9M$15.5M1.9%——
10 qtrssince 2024-Q1
Unchanged
0
NBP
NBP
ADR

NovaBridge Biosciences

6M$11.7M1.4%$50.07-96.11%
24 qtrssince 2020-Q3
Unchanged
0
CTNM

Contineum Therapeutics, Inc.

669,337$11M1.3%$17.61-6.93%
9 qtrssince 2024-Q2
Unchanged
0
MAZE

Maze Therapeutics, Inc.

366,028$10.9M1.3%$11.01+171.03%
6 qtrssince 2025-Q1
Unchanged
0
API
API
ADR

Agora, Inc.

2.1M$8.4M1.0%$4.16-4.09%
7 qtrssince 2024-Q4
Unchanged
0
TSM
TSM
ADR

Taiwan Semiconductor Manufacturing Company Ltd.

15,510$7.4M0.9%$310.97+53.17%
3 qtrssince 2025-Q4
Decreased
0
SGMT

Sagimet Biosciences Inc.

724,800$5.6M0.7%$8.80+12.27%
12 qtrssince 2023-Q3
Unchanged
0
NTES
NTES
ADR

NetEase, Inc.

34,999$4.5M0.5%$127.630.00%
1 qtr
New
53
GE

GE Aerospace

10,043$3.8M0.5%——
10 qtrssince 2024-Q1
Unchanged
0
$832.1M
AUM
35
Positions
Q2 2026
Filing
HI rating · 3.0/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$3,539,417,61622.5894446369%
2025-Q2$3,104,509,729-12.2875550213%
2025-Q3$4,090,754,76431.7681412233%
2025-Q4$3,103,678,081-24.129451408%
2026-Q1$1,672,822,114-46.101945165%
2026-Q2$832,072,843-50.2593350461%
Activity profile
$ moved · Q2'26
New4%Increased6%Decreased61%Exited28%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 3.5 years
<1Q11%1-4Q14%1-2Y9%2Y+66%

HHLR Advisors, Ltd. manages $832.1M across 35 positions as of Q2 2026. Top holdings: LEGN (20.8%), FUTU (19.9%), AVBP (16.4%). Fund DNA: High Conviction Activist. HoldingsIntel Score: 3/5.0.

Top holdings by portfolio weight

Total AUM$832M
LEGN20.77%
FUTU19.92%
AVBP16.40%
MRVL5.83%
VIPS5.53%
PDD4.58%
BEKE3.87%
CTKB3.54%
ALMR3.11%
BABA2.12%
Other1.87%

Portfolio allocation by GICS sector

Sectors9
Healthcare48.16%
Financial Services20.97%
Consumer Cyclical13.06%
Technology10.64%
Real Estate4.08%
Consumer Defensive1.96%
Communication Services0.57%
Industrials0.47%
Basic Materials0.10%

Behavioral investing profile

Checking access…
High Conviction Activist- primarily Healthcare, Financial Services, Consumer Cyclical
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Solid(3.0 / 5.0)
Holdings P&L14
Conviction65
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
2Q
VIPSVIPSVipshop Holdings Limited
Q2 2026 → Q3 2026+6.7M shares+$83.8M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Photo credits

Photo:“Warren Buffett at the 2015 SelectUSA Investment Summit”by USA International Trade Administration, cropped,public domainvia Wikimedia Commons

Photo:Leopold Aschenbrenner

Photo:“Cathie Wood ARK Invest Photo”by Caroline Wood, cropped,CC BY-SA 4.0via Wikimedia Commons

Photo:“Valeant Pharmaceuticals' Business Model (headshot)”by Senate Democrats, cropped,CC BY 2.0via Wikimedia Commons

Photo:Harlem Children's Zone

Photo:Mohnish Pabrai

Photo:“Peter Thiel on March 5 2026”by Kantei (The Prime Minister Office of Japan), cropped,CC BY 4.0via Wikimedia Commons

Photo:Charlotte FC

Photo:Ray Dalio

Photo:Himalaya Capital

Photo:Jonathan Kozowyk, Robin Hood

Photo:“Brad Gerstner at the White House 2025 (54581192563)”by The White House, cropped,public domainvia Wikimedia Commons

Photo:SuperReturn North America

Photo:Liz Linder, Harvard Kennedy School

Photo:Oaktree Capital Management

Photo:The Everglades Foundation

Photo:George Soros

Photo:Benjamin Meaker, Point72

Photo:Fundsmith

Photo:“Kenneth C. Griffin photo”by Paul Elledge, cropped,CC BY-SA 4.0via Wikimedia Commons

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used